HEU-EFS is a European Public-Private Partnership with the aim to develop an EU harmonized framework to improve the uptake of Early Feasibility Studies (EFS) for medical devices in the European Union.
EFS are a crucial part of the evidence-generation cycle for medical devices. Conducting these studies in a harmonized manner across Europe will bring significant benefits to patients, innovators, and the entire healthcare system.
Mission
The goal of the HEU-EFS project is to establish an EU methodology for Early Feasibility Studies in the EU. This will support the evidence generation pathway for medical device innovators.
Early Feasibility Studies (EFS) constitute a crucial phase in the journey towards medical device approval. An EFS is a clinical study conducted on a medical device in its nascent developmental stages. Typically involving a small number of participants, an EFS primarily assesses the initial clinical safety and performance of the device, providing guidance for product modifications. EFS plays a pivotal role in enabling medical device developers to focus their efforts on products with genuine potential to allow access for patients with unmet needs or suffering from life-threatening or highly debilitating disease.
Thanks to the HEU-EFS methodology, medical device innovators gain earlier insights into product development, leading to a smoother development process. The overall healthcare system benefits by driving innovation excellence and increasing the attractiveness of pursuing innovations in the EU. Ultimately, patients with limited or no alternative healthcare solutions benefit from access to innovative medical technologies.
Attract investment into innovation in Europe
Improve patient access with unmet medical needs
Enhance the evidence generation cycle
Foster clinical excellence
Twenty-two public and private consortium partners are collaborating over a four-year period to collect and systematize information on the regulatory framework and the current status of pre-market evidence generation programs. They aim to develop, test, and validate a robust and widely acceptable methodology through pilot use cases, ultimately making the EU a conducive environment for undertaking EFS.
EU Collaboration
Healthcare innovation
Clinical and scientific
excellence
Patient access
Among the main steps of the project are:
1
Conduct research and analysis on state of play of regulatory framework and characteristics and impacts of pre-market programs.
2
Build a sustainable network of stakeholders to promote the implementation of EFS in the EU.
3
Develop a sound, widely applicable and harmonised EU methodology and recommendations to uptake EFS.
4
Undertake pilot use cases to test the proposed methodological framework.
5
Develop instruments to monitor the performance of the EU EFS program.
6
Implement a dedicated, sustainable, open access informative online portal dedicated to EFS and disseminate the project results and recommendations.
PUBLIC CONSORTIUM
PRIVATE CONSORTIUM
Press release: Improving patient access to innovative medical technologies in the European Union
Find out
HEU-EFS KICK-OFF MEETING
30-31st OCTOBER 2023, MILAN: the launch of an innovative EU initiative to foster innovation in the MedTech sector
Find out
ISPOR News
The Harmonised Approach to Early Feasibility Studies for Medical Devices in the European Union (HEU-EFS) presented @ISPOR Europe 2023
Find out
CSI Focus for Heart Failure
HEU-EFS IHI initiative was presented at the annual leading conference in the field of device-based heart failure therapy
Find out
Call for interest: Applications welcome for HEU-EFS’s Patient Advisory Group
Applications remain open until 20 February 2024
Find outStay tuned to learn about our next events, subscribe here